June 2015
Volume 56, Issue 7
ARVO Annual Meeting Abstract  |   June 2015
Genetic engineering and characterization of Ebi3/CNTF fusokine
Author Affiliations & Notes
  • Lekha Nair
    National Eye Institute, National Institutes of Health, Bethesda, MD
  • Footnotes
    Commercial Relationships Lekha Nair, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3497. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Lekha Nair; Genetic engineering and characterization of Ebi3/CNTF fusokine. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3497.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Purpose: IL-27 and IL-35 are anti-inflammatory, heterodimeric cytokines in the IL-12 family of cytokines, which displays subunit and receptor promiscuity. IL-27 and IL-35 share subunit Ebi3, which is hypothesized to be responsible for the anti-inflammatory effects of IL-27 and IL-35. Ciliary neurotrophic factor (CNTF) is a nerve growth factor that has been shown to prevent neural cell damage. Though its effects on the immune system are unknown, it has been shown that CNTF can interact with receptors of the IL-6 family, many of which are homologous or shared by the IL-12 family cytokines. Our goal in this study is to genetically engineer recombinant CNTF and a covalently linked Ebi3 and CNTF fusokine and investigate whether they would have immunoregulatory functions in mouse models of CNS autoimmune diseases such as experimental autoimmune uveitis (EAU) and experimental autoimmune encephalomyelitis (EAE).

Methods: Method: The CNTF/Ebi3 fusokine consists of mouse Ebi3 and CNTF linked by a 22 amino acids linker-peptide between the two subunits. The cDNA construct encoding the single chain CNTF or CNTF/Ebi3 fusokine construct was cloned into pMIB/V5-HIS vector with expression under the direction of the Baculovirus immediate-early promoter, OpIE2, which allows for high-level, constitutive expression of the proteins in insect cells. The expression vector was transfected into High Five insect cells and stably transfected clones were subjected to several cycles of Blasticidin S HCl selection.

Results: Results: The secreted recombinant CNTF or Ebi3/CNTF has been partially purified by HIS-TAG affinity chromatography and size-exclusion chromatography using an FPLC system. The fusokine has been characterized by western blot analysis using antibodies against Ebi3 and the V5 protein tag. Consistent with the predicted molecular size, the Ebi3/CNTF fusokine is a protein at 54kDa.

Conclusions: Conclusion: We have successfully bio-engineered a 54 kDa Ebi3/CNTF fusokine and demonstrated its efficient secretion in insect cell cultures. Large-scale, ex-vivo production of the Ebi3/CNTF fusokine will undoubtedly allow in-depth analysis of the effects of this novel fusokine on T cell differentiation and its therapeutic potential in murine models of uveitis (EAU) and multiple sclerosis (EAE).


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.